back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-10-18 12:06 Tx date 2019-10-03 |
$ATE
Antibe Therapeutics Inc. |
Bourgeois, Nicolas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+66,667 vol |
4,339,187 | |
| Filed 2019-10-18 12:04 Tx date 2019-10-03 |
$ATE
Antibe Therapeutics Inc. |
Bourgeois, Nicolas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-66,667 vol |
533,333 | |
| Filed 2018-10-05 Tx date 2018-10-03 |
$ATE
Antibe Therapeutics Inc. |
Bourgeois, Nicolas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
97 - Other
|
+600,000 vol |
600,000 | |
| Filed 2018-10-05 Tx date 2015-10-15 |
$ATE
Antibe Therapeutics Inc. |
Bourgeois, Nicolas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-09-18 Tx date 2018-09-18 |
$ATE
Antibe Therapeutics Inc. |
Bourgeois, Nicolas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,170
+100,000 vol $0.2617 each |
4,272,520 | |
| Filed 2018-03-22 Tx date 2018-03-21 |
$ATE
Antibe Therapeutics Inc. |
Bourgeois, Nicolas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-265,000
-500,000 vol $0.53 each |
4,172,520 | |
| Filed 2017-04-04 Tx date 2017-03-31 |
$ATE
Antibe Therapeutics Inc. |
Bourgeois, Nicolas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$100,000
+500,000 vol $0.20 each |
500,000 | |
| Filed 2017-04-04 Tx date 2015-10-15 |
$ATE
Antibe Therapeutics Inc. |
Bourgeois, Nicolas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-19 Tx date 2015-10-15 |
$ATE
Antibe Therapeutics Inc. |
Bourgeois, Nicolas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,672,520 |